Association between diabetes overtreatment in older multimorbid patients and clinical outcomes: an ancillary European multicentre study

Antoine Christiaens*, Oliver Baretella, Cinzia Del Giovane, Nicolas Rodondi, Wilma Knol, Mike Peters, Emma Jennings, Denis O'Mahony, Anne Spinewine, Benoit Boland, Séverine Henrard

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
10 Downloads (Pure)

Abstract

Background: Diabetes overtreatment is a frequent and severe issue in multimorbid older patients with type 2 diabetes (T2D). Objective: This study aimed at assessing the association between diabetes overtreatment and 1-year functional decline, hospitalisation and mortality in older inpatients with multimorbidity and polypharmacy. Methods: Ancillary study of the European multicentre OPERAM project on multimorbid patients aged ≥70 years with T2D and glucose-lowering treatment (GLT). Diabetes overtreatment was defined according to the 2019 Endocrine Society guideline using HbA1c target range individualised according to the patient's overall health status and the use of GLT with a high risk of hypoglycaemia. Multivariable regressions were used to assess the association between diabetes overtreatment and the three outcomes. Results: Among the 490 patients with T2D on GLT (median age: 78 years; 38% female), 168 (34.3%) had diabetes overtreatment. In patients with diabetes overtreatment as compared with those not overtreated, there was no difference in functional decline (29.3% vs 38.0%, P = 0.088) nor hospitalisation rates (107.3 vs 125.8/100 p-y, P = 0.115) but there was a higher mortality rate (32.8 vs 21.4/100 p-y, P = 0.033). In multivariable analyses, diabetes overtreatment was not associated with functional decline nor hospitalisation (hazard ratio, HR [95%CI]: 0.80 [0.63; 1.02]) but was associated with a higher mortality rate (HR [95%CI]: 1.64 [1.06; 2.52]). Conclusions: Diabetes overtreatment was associated with a higher mortality rate but not with hospitalisation or functional decline. Interventional studies should be undertaken to test the effect of de-intensifying GLT on clinical outcomes in overtreated patients.

Original languageEnglish
Article numberafac320
JournalAge and ageing
Volume52
Issue number1
DOIs
Publication statusPublished - 1 Jan 2023

Keywords

  • diabetes overtreatment
  • glucose-lowering treatment
  • multimorbidity
  • older patients
  • older people
  • type 2 diabetes

Fingerprint

Dive into the research topics of 'Association between diabetes overtreatment in older multimorbid patients and clinical outcomes: an ancillary European multicentre study'. Together they form a unique fingerprint.

Cite this